Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma

Respiration

Volumn 83, Issue 4, 2012, Pages 308-315

  Takemura, Masaya ^a   Niimi, Akio ^a   Matsumoto, Hisako ^a   Ueda, Tetsuya ^a   Matsuoka, Hirofumi ^a   Yamaguchi, Masafumi ^a   Jinnai, Makiko ^a   Chin, Kazuo ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cough receptor sensitivity; Cough variant asthma; Cysteinyl leukotrienes; Eosinophils; Induced sputum; Leukotriene receptor antagonist; Montelukast

Indexed keywords

CAPSAICIN; LEUKOTRIENE B4; METHACHOLINE; MONTELUKAST; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2;

ADULT; AIRWAY RESPONSIVENESS; ANTIINFLAMMATORY ACTIVITY; ANTITUSSIVE ACTIVITY; ARTICLE; ASTHMA; CLINICAL ARTICLE; COUGH RECEPTOR SENSITIVITY; COUGH VARIANT ASTHMA; COUGHING; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL COUNT; GROUPS BY AGE; HUMAN; IMPULSE OSCILLOMETRY; LUNG FUNCTION; LUNG FUNCTION TEST; MEDIATOR RELEASE; OSCILLOMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; SPUTUM LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ACETATES; ADULT; AGED; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; COHORT STUDIES; COUGH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOTRIENE ANTAGONISTS; LINEAR MODELS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; QUINOLINES; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84859159409     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000332835     Document Type: Article

References (61)

1. Niimi A, Matsumoto H, Mishima M: Eosinophilic airway disorders associated with chronic cough. Pulm Pharmacol Ther 2009;22:114-120.
2. Niimi A: Geography and cough aetiology. Pulm Pharmacol Ther 2007;20:383-387.
3. Sano T, Ueda H, Bando H: A preliminary study of PEFR monitoring in patients with chronic cough. Lung 2004;182:285-295. (Pubitemid 40365048)
4. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F: Eosinophilic inflammation in cough variant asthma. Eur Respir J 1998;11:1064-1069. (Pubitemid 28281023)
5. Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF: Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol 2005;116:565-570. (Pubitemid 41267129)
6. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M: Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics. Clin Exp Allergy 2000;30:225-232. (Pubitemid 30095667)
7. Birring SS, Parker D, Brightling CE, Bradding P, Wardlaw AJ, Pavord ID: Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med 2004;169:15-19. (Pubitemid 38236160)
8. Fish JE, Jameson LS, Albright A, Norman PS: Modulation of the bronchomotor effects of chemical mediators by prostaglandin F2 alpha in asthmatic subjects. Am Rev Respir Dis 1984;130:571-574. (Pubitemid 15200007)
9. Kharitonov SA, Sapienza MA, Barnes PJ, Chung KF: Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. Am J Respir Crit Care Med 1998;158:1374-1378.
10. Choudry NB, Fuller RW, Pride NB: Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis 1989;140:137-141. (Pubitemid 19177094)
11. Ishiura Y, Fujimura M, Yamamori C, Nobata K, Myou S, Kurashima K, Takegoshi T: Thromboxane antagonism and cough in chronic bronchitis. Ann Med 2003;35:135-139. (Pubitemid 36638214)
12. Parsons WG 3rd, Roberts LJ 2nd: Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. J Immunol 1988;141:2413-2419.
13. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, Oh U: Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000;97:6155-6160. (Pubitemid 30367539)
14. Takemura M, Quarcoo D, Niimi A, Dinh QT, Geppetti P, Fischer A, Chung KF, Groneberg DA: Is TRPV1 a useful target in respiratory diseases? Pulm Pharmacol Ther 2008;21:833-839.
15. Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV: Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol 1998;102:935-942. (Pubitemid 29018310)
16. Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G: Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest 2007;132:1876-1881.
17. Biernacki WA, Kharitonov SA, Biernacka HM, Barnes PJ: Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients. Chest 2005;128:1958-1963. (Pubitemid 41507527)
18. Dicpinigaitis PV, Dobkin JB, Reichel J: Anti-tussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma 2002;39:291-297. (Pubitemid 34671102)
19. Spector SL, Tan RA: Effectiveness of montelukast in the treatment of cough variant asthma. Ann Allergy Asthma Immunol 2004;93:232-236. (Pubitemid 39280525)
20. Kita T, Fujimura M, Ogawa H, Nakatsumi Y, Nomura S, Ishiura Y, Myou S, Nakano S: Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough. Allergol Int 2010;59:185-192.
21. Kohno S, Ishida T, Uchida Y, Kishimoto H, Sasaki H, Shioya T, Tokuyama K, Niimi A, Nishi K, Fujimura M, Matsuse H, Suzaki H: The Japanese Respiratory Society guidelines for management of cough. Respirology 2006;11(suppl 4):S135-S186.
22. Goldman MD: Clinical application of forced oscillation. Pulm Pharmacol Ther 2001;14:341-350.
23. Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, Widdicombe J; European Respiratory Society (ERS): ERS guidelines on the assessment of cough. Eur Respir J 2007;29:1256-1276. (Pubitemid 46895388)
24. Takemura M, Niimi A, Minakuchi M, Matsumoto H, Ueda T, Chin K, Mishima M: Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest 2004;125:1352-1358. (Pubitemid 38501349)
25. Jinnai M, Niimi A, Ueda T, Matsuoka H, Takemura M, Yamaguchi M, Otsuka K, Oguma T, Takeda T, Ito I, Matsumoto H, Mishima M: Induced sputum concentrations of mucin in patients with asthma and chronic cough. Chest 2010;137:1122-1129.
26. Spanevello A, Vignola AM, Bonanno A, Confalonieri M, Crimi E, Brusasco V: Effect of methacholine challenge on cellular composition of sputum induction. Thorax 1999;54:37-39. (Pubitemid 29103749)
27. Yamaguchi M, Niimi A, Ueda T, Takemura M, Matsuoka H, Jinnai M, Otsuka K, Oguma T, Takeda T, Ito I, Matsumoto H, Hirai T, Chin K, Mishima M: Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther 2009;22:326-332.
28. Takeda T, Oga T, Niimi A, Matsumoto H, Ito I, Yamaguchi M, Matsuoka H, Jinnai M, Otsuka K, Oguma T, Nakaji H, Chin K, Mishima M: Relationship between small airway function and health status, dyspnea and disease control in asthma. Respiration 2010;80:120-126.
29. Matsumoto H, Niimi A, Jinnai M, Nakaji H, Takeda T, Oguma T, Otsuka K, Inoue H, Yamaguchi M, Matsuoka H, Ito I, Hirai T, Chin K, Mishima M: Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma. Respiration 2011;81:311-317.
30. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, Marchal F: The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003;22:1026-1041. (Pubitemid 37540659)
31. Marotta A, Klinnert MD, Price MR, Larsen GL, Liu AH: Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. J Allergy Clin Immunol 2003;112:317-322. (Pubitemid 36981371)
32. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: General considerations for lung function testing. Eur Respir J 2005;26:153-161.
33. Niimi A, Matsumoto H, Ueda T, Takemura M, Suzuki K, Tanaka E, Chin K, Mishima M, Amitani R: Impaired cough reflex in patients with recurrent pneumonia. Thorax 2003;58:152-153. (Pubitemid 36183004)
34. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T: Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981;80:600-606. (Pubitemid 12240034)
35. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M: Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 2003;168:983-988. (Pubitemid 37267177)
36. Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S: Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006;130:1726-1732. (Pubitemid 46033426)
37. Kawai S, Baba K, Matsubara A, Shiono H, Okada T, Yamaguchi E: The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma. J Asthma 2008;45:243-250. (Pubitemid 351549806)
38. Chaudhuri R, McMahon AD, Thomson LJ, MacLeod KJ, McSharry CP, Livingston E, McKay A, Thomson NC: Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 2004;113:1063-1070. (Pubitemid 38857987)
39. Jatakanon A, Lalloo UG, Lim S, Chung KF, Barnes PJ: Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 1999;54:234-237. (Pubitemid 29110503)
40. Groneberg DA, Niimi A, Dinh QT, Cosio B, Hew M, Fischer A, Chung KF: Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 2004;170:1276-1280. (Pubitemid 39657190)
41. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G: Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 2006;118:347-353. (Pubitemid 44160715)
42. Austen KF, Maekawa A, Kanaoka Y, Boyce JA: The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J Allergy Clin Immunol 2009;124:406-414, quiz 415-416.
43. Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID: Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000;162:878-882.
44. Pang L, Pitt A, Petkova D, Knox AJ: The COX-1/COX-2 balance in asthma. Clin Exp Allergy 1998;28:1050-1058. (Pubitemid 28432626)
45. Fujimura M, Hara J, Myou S: Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005;1:5.
46. Lee SY, Kim MK, Shin C, Shim JJ, Kim HK, Kang KH, Yoo SH, In KH: Substance P-immunoreactive nerves in endobronchial biopsies in cough-variant asthma and classic asthma. Respiration 2003;70:49-53.
47. Otsuka K, Niimi A, Matsumoto H, Ito I, Yamaguchi M, Matsuoka H, Jinnai M, Oguma T, Takeda T, Nakaji H, Chin K, Sasaki K, Aoyama N, Mishima M: Plasma substance P levels in patients with persistent cough. Respiration 2011;82:431-438.
48. McAlexander MA, Myers AC, Undem BJ: Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. J Pharmacol Exp Ther 1998;285:602-607. (Pubitemid 28237439)
49. Lai YL, Lee SP: Mediators in hyperpnea-induced bronchoconstriction of guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 1999;360:597-602.
50. Dicpinigaitis PV, Dobkin JB: Effect of zafirlukast on cough reflex sensitivity in asthmatics. J Asthma 1999;36:265-270. (Pubitemid 29267547)
51. Tantisira KG, Drazen JM: Genetics and pharmacogenetics of the leukotriene pathway. J Allergy Clin Immunol 2009;124:422-427.
52. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, Deykin A, DiMango E, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lemanske RF Jr, Leone FT, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Wechsler ME, Fahy JV: Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-790. (Pubitemid 46631789)
53. Korenblat PE, Kemp JP, Scherger JE, Minkwitz MC, Mezzanotte W: Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol 2000;84:217-225. (Pubitemid 30141604)
54. Tsai JJ, Chan SC, Ho CK, Su YC, Feng TC: Efficacy of zafirlukast in the treatment of patients with bronchial asthma. J Microbiol Immunol Infect 2001;34:63-70.
55. Creticos P, Knobil K, Edwards LD, Rickard KA, Dorinsky P: Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age. Ann Allergy Asthma Immunol 2002;88:401-409. (Pubitemid 34408567)
56. Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, Pavord D: Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001;95:999-1002. (Pubitemid 34013550)
57. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58:339-343. (Pubitemid 36411421)
58. Morice AH, McGarvey L, Pavord I; British Thoracic Society Cough Guideline Group: Recommendations for the management of cough in adults. Thorax 2006;61(suppl 1):i1-i24. (Pubitemid 44369412)
59. Niimi A, Matsumoto H, Minakuchi M, Kitaichi M, Amitani R: Airway remodelling in cough-variant asthma. Lancet 2000;356:564-565. (Pubitemid 30611864)
60. Matsumoto H, Niimi A, Takemura M, Ueda T, Tabuena R, Yamaguchi M, Matsuoka H, Hirai T, Muro S, Ito Y, Mio T, Chin K, Nishiyama H, Mishima M: Prognosis of cough variant asthma: a retrospective analysis. J Asthma 2006;43:131-135. (Pubitemid 43879428)
61. Takemura M, Niimi A, Matsumoto H, Ueda T, Yamaguchi M, Matsuoka H, Jinnai M, Chin K, Mishima M: Atopic features of cough variant asthma and classic asthma with wheezing. Clin Exp Allergy 2007;37:1833-1839. (Pubitemid 350145344)